Hepatopathy-thrombocytopenia syndrome (HTS) after actinomycin-D therapy: report of three cases and review of the literature

Pediatr Hematol Oncol. 2011 Apr;28(3):237-43. doi: 10.3109/08880018.2010.535118. Epub 2011 Jan 27.

Abstract

Hepatopathy-thrombocytopenia syndrome (HTS) is a severe complication very similar to vein occlusive disease (VOD), also known as hepatic sinusoidal obstructive syndrome (SOS), characterized by fever, hepatopathy (hepatomegaly with abnormal liver function tests), ascites, weight gain, jaundice, and thrombocytopenia (platelet count less than 25 × 10(3)/μL). It has been generally observed in patients with Wilms tumor, and is commonly associated to administration of actinomycin D. We report three children with Wilms tumor, with severe HTS/SOS, but had a different outcome, in spite of vigorous supportive therapy.

Publication types

  • Case Reports
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Antibiotics, Antineoplastic / adverse effects
  • Chemical and Drug Induced Liver Injury*
  • Dactinomycin / adverse effects*
  • Female
  • Humans
  • Infant
  • Kidney Neoplasms / drug therapy*
  • Male
  • Review Literature as Topic
  • Syndrome
  • Thrombocytopenia / chemically induced*
  • Wilms Tumor / drug therapy*

Substances

  • Antibiotics, Antineoplastic
  • Dactinomycin